Peptide-Based Cancer Vaccines

W. Martin Kast

$194

Hardback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

CRC Press
01 October 2000

Oncology; Biochemical immunology

The field of peptide based cancer vaccines has evolved tremendously in the last decade of this century. The exploration on how to apply the peptide knowledge for vaccination purposes began when it was demonstrated that these peptides after being mixed into adjuvants actually induced T cell responses that could prevent virus infections and tumor growth in experimental animal models. The results of animal models are currently translated into clinical applications with all their associated difficulties and heterogeneity. Initial promising data do appear, warranting further research in this area. This book pays tribute to key researchers in the field.

By: W. Martin Kast
Imprint: CRC Press
Country of Publication: United Kingdom
Dimensions: Height: 229mm, Width: 152mm,
Weight: 520g
ISBN: 9781587060267
ISBN 10: 1587060264
Pages: 231
Publication Date: 01 October 2000
Audience: College/higher education , Professional and scholarly , Professional & Vocational , A / AS level , Further / Higher Education
Format: Hardback
Publisher's Status: Active

1. Identification and Selection of T-Cell Epitopes Derived from Tumor-Associated Antigens for the Development of Immunotherapy for Cancer 2. Mutant Oncogene and Tumor Suppressor Gene Products and Fusion Proteins Created by Chromosomal Translocations as Targets for Cancer Vaccines 3. p53: A Target for T-Cell Mediated Immunotherapy 4. Critical Dependence of the Peptide Delivery Method on the Efficacy of Epitope Focused Immunotherapy 5. Cancer Peptide Vaccines in Clinical Trials 6. Carcinoembryonic Antigen (CEA) Peptides and Vaccines for Carcinoma 7. Studies of M UCl Peptides 8. Cytotoxic T Cell Epitopes and Tissue Distribution of the HER-2/neu Proto-Oncogene: Implications for Vaccine Development 9. Clinical Trials of HER-2/neu Peptide-Based Vaccines 10. Peptides in Prostate Cancer 11. Peptides in Cervical Cancer 12. Peptide Vaccines for the Treatment of Melanoma 13. GplOO and G250: Towards Specific Immunotherapy Employing Dendritic Cells in Melanoma and Renal Cell Carcinoma 14. Melanoma Peptide Clinical Trial

Kast, W. Martin

THE BIG SALE IS ON! TELL ME MORE

Peptide-Based Cancer Vaccines

W. Martin Kast

$194

Hardback

See Also

Contact Abbeys

Contact Galaxy

Contact Language

Contact Us

About ABBEY'S